Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation-Reference-Cited by-同舟云学术

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation

Published:2010-10-08 Issue:11 Volume:128 Page:2653-2662
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Widenmeyer Melanie,Shebzukhov Yuriy,Haen Sebastian P.,Schmidt Diethard,Clasen Stephan,Boss Andreas,Kuprash Dmitri V.,Nedospasov Sergei A.,Stenzl Arnulf,Aebert Hermann,Wernet Dorothee,Stevanović Stefan,Pereira Philippe L.,Rammensee Hans-Georg,Gouttefangeas Cécile

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma;Machi;World J Surg,2005

2. Image-guided radiofrequency ablation of renal cell carcinoma;Boss;Eur Radiol,2007

3. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer;Wong;J Clin Oncol,2010

4. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation;Gillams;Eur Radiol,2009

5. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience;Siperstein;Ann Surg,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens;Frontiers in Oncology;2024-08-26

2. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma;Frontiers in Immunology;2024-01-29

3. Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape;International Journal of Molecular Sciences;2023-07-14

4. Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors;Biology;2023-07-13

5. A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence;Cancers;2023-05-17